Conference Spotlight Posts
Conference Spotlight
A Deep Dive into Cell and Gene Therapy Regulatory Considerations: Part Two
Jerry Chapman
May 25, 2023
Conference Spotlight
A Deep Dive into Cell and Gene Therapy Regulatory Considerations: Part One
Jerry Chapman
April 27, 2023
Conference Spotlight
Is Raw FDA Data Skewing Your Analyses?
Redica Systems
March 23, 2023
Conference Spotlight
Should ICH Tackle Standard Development for CGT Products?
Jerry Chapman
March 8, 2023
Conference Spotlight
FDA on the Evolution of Biologics Inspections: Part III
Jerry Chapman
January 26, 2023
Conference Spotlight
How “Inevitable” Data Integrity Issues Cause Havoc: Part II
Redica Systems
December 12, 2022
Conference Spotlight
FDA on the Evolution of Biologics Inspections: Part II
Jerry Chapman
December 6, 2022
Conference Spotlight
FDA on the Evolution of Biologics Inspections: Part I
Jerry Chapman
November 28, 2022
Conference Spotlight
The Evolving Clinical Trial Ecosystem
Jerry Chapman
November 2, 2022